Strs Ohio Oncocyte Corp Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$0.86 - $1.53 $43,258 - $76,959	-50,300 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$3.53 - $5.89 $91,427 - $152,551	25,900 Added 106.15%	50,300 $179,000
Q2 2021 Jul 26, 2021	BUY	$3.77 - $6.0 $91,988 - $146,400	24,400 New	24,400 $140,000
Q2 2018 Aug 06, 2018	SELL	$2.0 - $3.3 $9,200 - $15,180	-4,600 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$4.55 - $7.55 $20,930 - $34,730	4,600	4,600 $34,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $326M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.